ponatinib,blinatumomab
amgen,takeda,incyte,otsuka,astellas
['ph+ all', 'ponatinib', 'blinatumomab']
#asco #chemo-free ponatinib plus blinatumomab for adult pts with new ph+ all led to 93% 2yr survival. no more bad hair days! 
Cancer specialist searching the world for better therapy